| Literature DB >> 16824756 |
Hui Li1, John Tatlock, Angelica Linton, Javier Gonzalez, Allen Borchardt, Peter Dragovich, Tanya Jewell, Tom Prins, Ru Zhou, Julie Blazel, Hans Parge, Robert Love, Michael Hickey, Chau Doan, Stephanie Shi, Rohit Duggal, Cristina Lewis, Shella Fuhrman.
Abstract
A novel class of non-nucleoside HCV NS5B polymerase inhibitors has been identified from screening. A co-crystal structure revealed an allosteric binding site in the protein that required a unique conformational change to accommodate inhibitor binding. Herein we report the structure-activity relationships (SARs) of this novel class of dihydropyrone-containing compounds that show potent inhibitory activities against the HCV RNA polymerase in biochemical assays.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16824756 DOI: 10.1016/j.bmcl.2006.06.065
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823